Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/29932| Title: | Ocrelizumab treatment satisfaction in patients with suboptimal response to previous disease-modifying therapies | Authors: | VAN WIJMEERSCH, Bart Buffels, R. Clinch, S. Kuhelj, R. Wei, W. Vermersch, P. |
Issue Date: | 2019 | Publisher: | SAGE PUBLICATIONS LTD | Source: | MULTIPLE SCLEROSIS JOURNAL, 25(S2), p. 824-825 | Notes: | [Van Wijmeersch, B.] Univ Hasselt, Overpelt, Belgium. [Van Wijmeersch, B.] Rehabil & MS Ctr Overpelt, Overpelt, Belgium. [Buffels, R.; Kuhelj, R.; Wei, W.] F Hoffmann La Roche Ltd, Basel, Switzerland. [Clinch, S.] F Hoffmann La Roche Ltd, Welwyn Garden City, Herts, England. [Vermersch, P.] Univ Lille, Lille, France. | Keywords: | Clinical Neurology; Neurosciences | Document URI: | http://hdl.handle.net/1942/29932 | ISSN: | 1352-4585 | e-ISSN: | 1477-0970 | ISI #: | 000485303103278 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.